Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD Source: Eur Respir J 2008; 32: 962-969 Year: 2008
Relationship between lung function impairment and incidence or recurrence of cardiovascular disease in a middle-aged cohort Source: Annual Congress 2007 - Longitudinal and cross sectional risk factors for COPD Year: 2007
Lung function impairment in adult asthma increases the risk of systemic inflammation Source: International Congress 2015 – Immune aspects of asthma and other airway diseases Year: 2015
Systemic manifestations and comorbidities of COPD Source: Eur Respir J 2009; 33: 1165-1185 Year: 2009
Cardio-vascular co-morbidities and severity of lung function impairment in a COPD cohort Source: Eur Respir J 2006; 28: Suppl. 50, 160s Year: 2006
Asthma in the elderly Source: Eur Respir Mon; 2009: 43: 56–76 Year: 2009
The prevalence and characteristics of pulmonary hypertension in severe COPD Source: International Congress 2016 – Pulmonary hypertension in lung disease Year: 2016
The association among balance, activity limitation, dyspnea and vulnerability in chronic obstructive pulmonary diseases Source: Annual Congress 2013 –Exercise, physiotherapy techniques and assessment methods in COPD and asthma Year: 2013
Metabolic regulation during the co-existence of COPD and DM type2 Source: International Congress 2016 – Features and impact of comorbidities in COPD Year: 2016
Air trapping is associated with exercise capacity in persons without overt obstructive lung disease Source: International Congress 2016 – Mechanisms of symptoms and exercise limitation in health and disease Year: 2016
COPD coronary/peripheral vascular disease Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases Year: 2006
Correlation between exercise capacity with FVC%, FEV1% and RV% in patients with airways diseases and severe and very severe lung function obstruction Source: International Congress 2016 – Respiratory muscles and airways function: from physiology to clinical implications Year: 2016
Decline of the lung function and quality of glycemic control in type 2 diabetes mellitus Source: Annual Congress 2013 –Novel biomarkers and old parameters in clinical management of lung diseases Year: 2013
Metabolic syndrome, systemic inflammation and Framingham risk score are independent risk factors for reduced lung function in healthy Korean adults Source: Annual Congress 2013 –Monitoring lung function in airway diseases Year: 2013
COPD, obesity and non-invasive ventilation Source: Annual Congress 2013 –Long-term NIV: COPD, sleep, obesity and outcomes Year: 2013
Aging, and not diabetes or hypertension, induces mucociliary clearance dysfunction in a general population Source: Annual Congress 2010 - New diagnostic approaches in respiratory function Year: 2010
The association between lung function and properties of the cardiovascular system in childhood Source: Annual Congress 2013 –Paediatric respiratory epidemiology: new understandings of lung function, disorders of prematurity and chronic airway diseases Year: 2013
COPD prevalence is increased in lung cancer, independent of age, sex and smoking history Source: Eur Respir J 2009; 33: 380-386 Year: 2009
Cardiovascular status of patients with a severe form of COPD Source: International Congress 2015 – Diagnosing and management of COPD in primary care Year: 2015